Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

FDA revises Lilly's COVID-19 antibody combo EUA for use after exposure to virus

09/16/2021 | 03:55pm EDT

Sept 16 (Reuters) - The U.S. Food and Drug Administration said on Thursday it has revised its emergency use authorization for Eli Lilly's COVID-19 antibody cocktail to include for use in patients who have been exposed to the virus and are at high risk for progression to severe disease.

The cocktail, bamlanivimab and etesevimab, was authorized in February for use in people 12 years and above with mild-to-moderate infection and are at high risk for progression to severe COVID-19.

However, the FDA said on Thursday the cocktail is not a substitute for vaccination against COVID-19. (https://bit.ly/2XqtHln)

The FDA said that bamlanivimab and etesevimab, which are administered together, could be also used as post-exposure prevention for patients who are not fully vaccinated or who are not expected to mount an adequate immune response to complete vaccination or have been exposed to an individual infected with the virus.

The revision comes a day after the U.S. government bought 388,000 additional doses of Lilly's COVID-19 antibody therapy. (Reporting by Dania Nadeem in Bengaluru; Editing by Shailesh Kuber)


© Reuters 2021
Latest news "Economy & Forex"
03:43aFoxconn bullish on electric vehicle prospects as it shows off three prototypes
RE
03:42aEU's Borrell 'optimistic' about possible new Iran talks
RE
03:33aSouth African rand weaker as soft Chinese data prompts risk aversion
RE
03:22aChina coking coal, coke futures surge to record highs on supply woes
RE
03:22aChina coking coal, coke futures surge to record highs on supply woes
RE
03:17aAustralia's Aristocrat Leisure makes $2.9 billion bet on online gambling provider Playtech
RE
03:16aChina's power woes may worsen as demand surges amid coal supply lag
RE
03:16aChina refinery throughput hits 16-month low as quota, power crunch bites
RE
03:15aJGB yields track U.S. yields higher ahead of 20-year note auction
RE
03:13aStellantis, LGES to form battery JV for North American market
RE
Latest news "Economy & Forex"